Literature DB >> 11160193

Murine B1 B cells require IL-5 for optimal T cell-dependent activation.

L D Erickson1, T M Foy, T J Waldschmidt.   

Abstract

T helper cell-driven activation of murine B cells has been shown to depend upon CD40-CD40 ligand (CD40L) interactions and a defined set of cytokines. These observations are primarily based on the use of conventional B cells obtained from the spleen. Therefore, it is presently unclear whether all mature B cell subsets found in the mouse have an equal dependence upon CD40-CD40L interactions and use the same T cell-derived cytokines. The present study tested the response of splenic follicular and marginal zone as well as peritoneal B2 and B1 B cells to Th cell stimulation. Splenic and peritoneal B cell subsets were sort purified based on CD23 expression, and cultured with rCD40L and cytokines or Th2 cells. The results demonstrate that follicular, marginal zone, and peritoneal B2 B cells require CD40-CD40L interactions and preferentially use IL-4 for optimal proliferation, differentiation, and isotype switching. In contrast, peritoneal B1 B cells use IL-5 in conjunction with CD40-CD40L interactions for maximal Th cell-dependent responses. Furthermore, B1 B cells are capable of proliferating, differentiating, and isotype switching in the absence of CD40-CD40L interactions. B1 B cells are able to respond to Th2 clones in the presence of anti-CD40L mAb as well as to Th2 clones derived from CD40L(-/-) mice. The CD40-CD40L-independent response of B1 B cells is attributable to the presence of both IL-4 and IL-5, and may explain the residual Ab response to T cell-dependent Ags in CD40L- or CD40-deficient mice, and in X-linked hyper-IgM (X-HIM) patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160193      PMCID: PMC2832833          DOI: 10.4049/jimmunol.166.3.1531

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  47 in total

1.  Defective B-1 cell development and impaired immunity against Angiostrongylus cantonensis in IL-5R alpha-deficient mice.

Authors:  T Yoshida; K Ikuta; H Sugaya; K Maki; M Takagi; H Kanazawa; S Sunaga; T Kinashi; K Yoshimura; J Miyazaki; S Takaki; K Takatsu
Journal:  Immunity       Date:  1996-05       Impact factor: 31.745

2.  The characterization of four monoclonal antibodies specific for mouse IL-5 and development of mouse and human IL-5 enzyme-linked immunosorbent.

Authors:  J H Schumacher; A O'Garra; B Shrader; A van Kimmenade; M W Bond; T R Mosmann; R L Coffman
Journal:  J Immunol       Date:  1988-09-01       Impact factor: 5.422

3.  B1 and B2 cells differ in their potential to switch immunoglobulin isotype.

Authors:  D M Tarlinton; M McLean; G J Nossal
Journal:  Eur J Immunol       Date:  1995-12       Impact factor: 5.532

Review 4.  Immune regulation by CD40 and its ligand GP39.

Authors:  T M Foy; A Aruffo; J Bajorath; J E Buhlmann; R J Noelle
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

5.  Different CD40-mediated signaling events require distinct CD40 structural features.

Authors:  B S Hostager; Y Hsing; D E Harms; G A Bishop
Journal:  J Immunol       Date:  1996-08-01       Impact factor: 5.422

6.  Differential expression of CD22 (Lyb8) on murine B cells.

Authors:  L D Erickson; L T Tygrett; S K Bhatia; K H Grabstein; T J Waldschmidt
Journal:  Int Immunol       Date:  1996-07       Impact factor: 4.823

7.  Membrane-bound CD154, but not CD40-specific antibody, mediates NF-kappaB-independent IL-6 production in B cells.

Authors:  M Baccam; G A Bishop
Journal:  Eur J Immunol       Date:  1999-12       Impact factor: 5.532

8.  Characterization of CD40 signaling determinants regulating nuclear factor-kappa B activation in B lymphocytes.

Authors:  Y Hsing; B S Hostager; G A Bishop
Journal:  J Immunol       Date:  1997-11-15       Impact factor: 5.422

9.  IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses.

Authors:  M Kopf; F Brombacher; P D Hodgkin; A J Ramsay; E A Milbourne; W J Dai; K S Ovington; C A Behm; G Köhler; I G Young; K I Matthaei
Journal:  Immunity       Date:  1996-01       Impact factor: 31.745

10.  Role of membrane immunoglobulin (Ig) crosslinking in membrane Ig-mediated, major histocompatibility-restricted T cell-B cell cooperation.

Authors:  H P Tony; N E Phillips; D C Parker
Journal:  J Exp Med       Date:  1985-11-01       Impact factor: 14.307

View more
  29 in total

1.  Polyreactive antigen-binding B (PAB-) cells are widely distributed and the PAB population consists of both B-1+ and B-1- phenotypes.

Authors:  Z-H Zhou; A L Notkins
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

2.  IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis.

Authors:  Christoph J Binder; Karsten Hartvigsen; Mi-Kyung Chang; Marina Miller; David Broide; Wulf Palinski; Linda K Curtiss; Maripat Corr; Joseph L Witztum
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

3.  Presentation of high antigen-dose by splenic B220(lo) B cells fosters a feedback loop between T helper type 2 memory and antibody isotype switching.

Authors:  Jason S Ellis; F Betul Guloglu; Habib Zaghouani
Journal:  Immunology       Date:  2016-01-28       Impact factor: 7.397

4.  Intradermal active full-length DNA Aβ42 immunization via electroporation leads to high anti-Aβ antibody levels in wild-type mice.

Authors:  Roger N Rosenberg; Min Fu; Doris Lambracht-Washington
Journal:  J Neuroimmunol       Date:  2018-06-11       Impact factor: 3.478

5.  DNA beta-amyloid(1-42) trimer immunization for Alzheimer disease in a wild-type mouse model.

Authors:  Doris Lambracht-Washington; Bao-Xi Qu; Min Fu; Todd N Eagar; Olaf Stüve; Roger N Rosenberg
Journal:  JAMA       Date:  2009-10-28       Impact factor: 56.272

6.  Helix-loop-helix factor inhibitor of differentiation 3 regulates interleukin-5 expression and B-1a B cell proliferation.

Authors:  Heather M Perry; Stephanie N Oldham; Shawn P Fahl; Xuchu Que; Ayelet Gonen; Daniel B Harmon; Sotirios Tsimikas; Joseph L Witztum; Timothy P Bender; Coleen A McNamara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-10-10       Impact factor: 8.311

7.  Attenuated liver fibrosis in the absence of B cells.

Authors:  Tatiana I Novobrantseva; Gerard R Majeau; Aldo Amatucci; Sophia Kogan; Ian Brenner; Stefano Casola; Mark J Shlomchik; Victor Koteliansky; Paula S Hochman; Alexander Ibraghimov
Journal:  J Clin Invest       Date:  2005-11       Impact factor: 14.808

Review 8.  Biology of the eosinophil.

Authors:  Carine Blanchard; Marc E Rothenberg
Journal:  Adv Immunol       Date:  2009       Impact factor: 3.543

9.  Sensing Microbial Viability through Bacterial RNA Augments T Follicular Helper Cell and Antibody Responses.

Authors:  Gaetan Barbet; Leif E Sander; Matthew Geswell; Irina Leonardi; Andrea Cerutti; Iliyan Iliev; J Magarian Blander
Journal:  Immunity       Date:  2018-03-13       Impact factor: 31.745

10.  The endogenous danger signal, crystalline uric acid, signals for enhanced antibody immunity.

Authors:  Marshall D Behrens; Wolfgang M Wagner; Christopher J Krco; Courtney L Erskine; Kimberly R Kalli; James Krempski; Ekram A Gad; Mary L Disis; Keith L Knutson
Journal:  Blood       Date:  2007-11-20       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.